Cercar
07/10/2025
Emergent Carotid Artery Stenting in Patients With Acute Ischemic Stroke With Tandem Lesions: One-Year Follow-Up Results From the SECURIS Study
Ezcurra-Diaz, G, Cardona, P, Rodriguez-Villatoro, N, Cubero, ADM, Flores-Pina, B, Figueras-Aguirre, GL, Fernández-Perez, I, Xuclà-Ferrarons, T, Purroy, F, Flores, A, Guasch-Jimenez, M, Lambea-Gil, A, Prats-Sanchez, L, Ramos-Pachón, A, Martinez-Domeño, A, Marti-Fabregas, J, Fernández-Vidal, JM, Abilleira, S, Salvat-Plana, M, Núñez-Guillen, A, Lara-Rodriguez, B, Rodriguez-Luna, D, Hernandez, D, Vázquez, AR, Cabero-Arnold, A, Albarracin, AM, Cánovas, D, Camps-Renom, P. Emergent Carotid Artery Stenting in Patients With Acute Ischemic Stroke With Tandem Lesions: One-Year Follow-Up Results From the SECURIS Study. NEUROLOGY. 2025; 105(7)DOI:10.1212/WNL.0000000000214067. PMID:40939130. IF:8.500(Q1/1D).
01/10/2025
Trends in revascularization therapies for patients with acute stroke with large infarcts: a population-based study
Cubero, ADM, Rodríguez-Vázquez, A, Rosa, I, Rudilosso, S, Serrano, M, Renú, A, Cabero-Arnold, A, Blasco, J, Amaro, S, Llull, L, Molina, CA, Portela, PC, Camps-Renom, P, Millan, M, Figueras-Aguirre, G, Rodríguez-Campello, A, Silva, Y, Purroy, F, Salvat, M, Vargas, M, Urra, X, Chamorro, A. Trends in revascularization therapies for patients with acute stroke with large infarcts: a population-based study. Journal of NeuroInterventional Surgery. 2025; 17(10)DOI:10.1136/jnis-2025-023252. PMID:40316318. IF:4.300(Q1/1D).
27/09/2025
Minimally invasive evacuation for spontaneous supratentorial haemorrhage: scoping for candidates and hypothetical logistic burdens in a pragmatic scenario
Mosteiro, A, Coronel-Coronel, M, Pedrosa, L, Lambea-Gil, A, Torne, R, Camps-Renom, P, Prats-Sanchez, L, Marti-Fabregas, J, Amaro, S, Ramos-Pachón, A. Minimally invasive evacuation for spontaneous supratentorial haemorrhage: scoping for candidates and hypothetical logistic burdens in a pragmatic scenario. NEUROSURGICAL REVIEW. 2025; 48(1)DOI:10.1007/s10143-025-03823-4. PMID:41014383. IF:2.500(Q1/3D).
01/09/2025
European Stroke Organisation (ESO) standard operating procedure for white papers (expert consensus based clinical guidance)
de Sousa, DA, Zietz, A, Zedde, M, Katsanos, AH, Li, LX, Marti-Fabregas, J, Nolte, CH, Podlasek, A, Poli, S, Purrucker, J, Roaldsen, MB, Schellinger, PD, Strbian, D, Tsivgoulis, G, Tsokani, S, Veroniki, AA, Quinn, TJ. European Stroke Organisation (ESO) standard operating procedure for white papers (expert consensus based clinical guidance). European Stroke Journal. 2025; 10(3)DOI:10.1177/23969873251316430. PMID:39904756. IF:4.500(Q1/2D).
12/08/2025
Mobile Stroke Units An Investment, Not a Luxury
Ossa, NPD. Mobile Stroke Units An Investment, Not a Luxury. NEUROLOGY. 2025; 105(3)DOI:10.1212/WNL.0000000000213960. PMID:40627816. IF:8.500(Q1/1D).
01/08/2025
HDL from patients with recent ischemic stroke and carotid atherosclerosis shows less antioxidant enzymes and more inflammatory potential than patients with asymptomatic carotid atherosclerosis
Puig, N, Camps-Renom, P, Lambea, A, Guasch-Jiménez, M, Solé, A, Rives, J, Sanchez-Quesada, JL, Benitez, S. HDL from patients with recent ischemic stroke and carotid atherosclerosis shows less antioxidant enzymes and more inflammatory potential than patients with asymptomatic carotid atherosclerosis. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).
01/08/2025
Secretome from recently symptomatic carotid plaques present higher content of inflammatory and antioxidant molecules compared to asymptomatic plaques
Puig, N, Camps-Renom, P, Pérez, B, Aguilera-Simón, A, Solé, A, Camacho, M, Jiménez-Altayó, F, Sanchez-Quesada, JL, Benitez, S. Secretome from recently symptomatic carotid plaques present higher content of inflammatory and antioxidant molecules compared to asymptomatic plaques. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).
01/08/2025
Efficacy and safety of mechanical thrombectomy in acute ischaemic stroke secondary to infective endocarditis
Lapeña, P, Urra, X, Llopis, J, Hernández-Meneses, M, Cuervo, G, Maisterra, O, Escrihuela-Vidal, F, Prats-Sánchez, L, Sáez, C, Olmos, C, Hernández-Fernández, F, Werner, M, de la Ossa, NP, Quintana, E, Moreno, A, Chamorro, A, Miró, JM. Efficacy and safety of mechanical thrombectomy in acute ischaemic stroke secondary to infective endocarditis. CLINICAL MICROBIOLOGY AND INFECTION. 2025; 31(8)DOI:10.1016/j.cmi.2025.02.008. PMID:39924109. IF:8.500(Q1/1D).
01/07/2025
Residual Risk of Recurrent Stroke Despite Anticoagulation in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
McCabe, JJ, Cheung, Y, Foley, M, Brennan, SO, Buckley, J, Renom, PC, Cassidy, T, Collins, R, Dolan, E, Grosse, GM, Harbison, J, James, K, Khadjooi, K, Induruwa, I, Katan, M, Maher, S, O'Connor, M, O'Donnell, M, Purroy, F, Synott, P, Kelly, PJ. Residual Risk of Recurrent Stroke Despite Anticoagulation in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis. JAMA Neurology. 2025; 82(7)DOI:10.1001/jamaneurol.2025.1337. PMID:40394992. IF:21.300(Q1/1D).
01/04/2025
Rationale and Design of the Statin Use in Intracerebral Hemorrhage Patients (SATURN) Trial
Marchina, S, Yeatts, SD, Foster, LD, Janis, S, Shoamanesh, A, Khatri, P, Bernstein, K, Perlmutter, A, Stever, C, Heistand, EC, Broderick, JP, Greenberg, SM, Leira, EC, Rosand, J, Lioutas, VA, Salman, RA, Tirschwell, D, Marti-Fabregas, J, Selim, M. Rationale and Design of the Statin Use in Intracerebral Hemorrhage Patients (SATURN) Trial. CEREBROVASCULAR DISEASES. 2025; 54(2)DOI:10.1159/000538195. PMID:38493765. IF:1.500(Q3/8D).
01/02/2025
Alterations in LDL and HDL after an ischemic stroke associated with carotid atherosclerosis are reversed after 1 year
Puig, N, Camps-Renom, P, Hermansson, M, Aguilera-Simón, A, Marín, R, Bautista, O, Rotllan, N, Blanco-Sanroman, N, Domine, MC, Öörni, K, Sánchez-Quesada, JL, Benitez, S. Alterations in LDL and HDL after an ischemic stroke associated with carotid atherosclerosis are reversed after 1 year. JOURNAL OF LIPID RESEARCH. 2025; 66(2)DOI:10.1016/j.jlr.2024.100739. PMID:39746448. IF:4.100(Q2/4D).
06/12/2024
Atherogenic circulating lipoproteins in ischemic stroke
Benitez, S, Puig, N, Camps-Renom, P, Sánchez-Quesada, JL. Atherogenic circulating lipoproteins in ischemic stroke. Frontiers in Cardiovascular Medicine. 2024; 11DOI:10.3389/fcvm.2024.1470364. PMID:39713216. IF:2.900(Q2/4D).
01/09/2024
Predicting Recanalization Failure With Conventional Devices During Endovascular Treatment Related to Vessel Occlusion
Flores, A, Elizalde, M, Seró, L, Ustrell, X, Avivar, Y, Pellisé, A, Rodriguez, P, Monterde, A, Lara, L, Gonzalez-de-Echavarri, JM, Cuba, V, Gisbert, MR, Requena, M, Molina, CA, Chamorro, A, de la Ossa, NP, Cardona, P, Cánovas, D, Purroy, F, Silva, Y, Camzpello, A, Marti-Fabregas, J, Abilleira, S, Ribó, M. Predicting Recanalization Failure With Conventional Devices During Endovascular Treatment Related to Vessel Occlusion. Stroke-Vascular And Interventional Neurology. 2024; 4(5)DOI:10.1161/SVIN.124.001371. PMID:. IF:(Q/D).
01/08/2024
SECRETOME FROM EPICARDIAL ADIPOSE TISSUE OF PATIENTS WITH OBESITY INDUCES INFLAMMATION IN HUMAN CARDIOMYOCYTES
Puig, N, Rives, J, Miñambres, I, Casaldaguila, B, Gil, P, Grau-Agramunt, M, Pérez, A, Sanchez-Quesada, JL, Benitez, S. SECRETOME FROM EPICARDIAL ADIPOSE TISSUE OF PATIENTS WITH OBESITY INDUCES INFLAMMATION IN HUMAN CARDIOMYOCYTES. ATHEROSCLEROSIS. 2024; 395DOI:. PMID:. IF:5.700(Q1/1D).
01/08/2024
DELETERIOUS ROLE OF FREE FATTY ACID AND CERAMIDE SPECIES IN THE ALTERATIONS INDUCED BY EPICARDIAL FAT FROM DIABETIC PATIENTS ON CARDIOMYOCYTE FUNCTION
Puig, N, Rives, J, Miñambres, I, Casaldaguila, B, Gil, P, Grau-Agramunt, M, Pérez, A, Sánchez-Quesada, JL, Benitez, S. DELETERIOUS ROLE OF FREE FATTY ACID AND CERAMIDE SPECIES IN THE ALTERATIONS INDUCED BY EPICARDIAL FAT FROM DIABETIC PATIENTS ON CARDIOMYOCYTE FUNCTION. ATHEROSCLEROSIS. 2024; 395DOI:. PMID:. IF:5.700(Q1/1D).
23/07/2024
Influence of Hospital Type on Outcomes of Patients With Acute Spontaneous Intracerebral Hemorrhage
Marti-Fabregas, J, Ramos-Pachón, A, Prats-Sanchez, L, Núñez-Guillén, A, Rodríguez, BL, Rodriguez-Luna, D, Amaro, S, Silva, Y, Rodriguez-Campello, A, Puig, I, Gomez-Choco, M, Vázquez-Justes, D, Guanyabens, N, Cocho, D, Cánovas, D, Steinhauer, EG, Llull, L, Guasch-Jiménez, M, Martinez-Domeño, A, Marin, R, Lambea-Gil, A, Díaz, GE, Paipa-Merchan, A, Quesada, H, Casadevall, MP, Wenger, D, Pancorbo, O, Seró, L, Pérez, J, Costa, X, Zaragoza, J, Rodríguez-Villatoro, N, Catena, E, Calvo, NM, Krupinski, J, de la Ossa, NP, Abilleira, S, Salvat-Planas, M, Fagundez, O, Camps-Renom, P. Influence of Hospital Type on Outcomes of Patients With Acute Spontaneous Intracerebral Hemorrhage. NEUROLOGY. 2024; 103(2)DOI:10.1212/WNL.0000000000209539. PMID:38875516. IF:8.500(Q1/1D).
14/05/2024
Effects of Achieving Rapid, Intensive, and Sustained Blood Pressure Reduction in Intracerebral Hemorrhage Expansion and Functional Outcome
Rodriguez-Luna, D, Pancorbo, O, Llull, L, Silva, Y, Prats-Sanchez, L, Muchada, M, Rudilosso, S, Terceño, M, Ramos-Pachón, A, Guillamon, MH, Coscojuela, P, Blasco, J, Perez-Hoyos, S, Chamorro, A, Molina, CA. Effects of Achieving Rapid, Intensive, and Sustained Blood Pressure Reduction in Intracerebral Hemorrhage Expansion and Functional Outcome. NEUROLOGY. 2024; 102(9)DOI:10.1212/WNL.0000000000209244. PMID:38598746. IF:8.500(Q1/1D).
09/04/2024
Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds
Prats-Sanchez, L, Camps-Renom, P, Nash, PS, Wilson, D, Ambler, G, Best, JG, Guasch-Jiménez, M, Ramos-Pachón, A, Martinez-Domeño, A, Lambea-Gil, A, Díaz, GE, Guisado-Alonso, D, Du, HW, Salman, RA, Jäger, HR, Lip, GY, Ay, H, Jung, S, Bornstein, NM, Gattringer, T, Eppinger, S, van Dam-Nolen, DH, Koga, M, Toyoda, K, Fluri, F, Phan, TG, Srikanth, VK, Heo, JH, Bae, HJ, Kelly, PJ, Imaizumi, T, Staals, J, Köhler, S, Yakushiji, Y, Orken, DN, Smith, EE, Wardlaw, JM, Chappell, FM, Makin, SD, Mas, JL, Calvet, D, Bordet, R, Chen, CP, Veltkamp, R, Kandiah, N, Simister, RJ, De Leeuw, FE, Engelter, ST, Peters, N, Soo, YO, Zietz, A, Hendrikse, J, Mess, WH, Werring, DJ, Marti-Fabregas, J. Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds. NEUROLOGY. 2024; 102(7)DOI:10.1212/WNL.0000000000209173. PMID:38471056. IF:8.500(Q1/1D).
01/02/2024
Asymptomatic parenchymal haemorrhage following endovascular treatment: Impact on functional outcome in patients with acute ischaemic stroke
Toscano-Prat, C, Martínez-González, JP, Guasch-Jiménez, M, Ramos-Pachón, A, Martí-Fàbregas, J, Blanco-Sanroman, N, Coronel-Coronel, MF, Domine, MC, Martínez-Domeño, A, Prats-Sánchez, L, Marín-Bueno, R, Aguilera-Simón, A, Lambea-Gil, A, Ezcurra-Díaz, G, Camps-Renom, P. Asymptomatic parenchymal haemorrhage following endovascular treatment: Impact on functional outcome in patients with acute ischaemic stroke. EUROPEAN JOURNAL OF NEUROLOGY. 2024; 31(2)DOI:10.1111/ene.16112. PMID:37909802. IF:3.900(Q1/3D).
01/02/2024
Left atrial appendage occlusion in patients with spontaneous intracerebral hemorrhage: An observational study
Moliner-Abós, C, Albertí-Vall, B, Millan-Alvarez, X, Camps-Renom, P, Guasch-Jiménez, M, Asmarats-Serra, L, Lambea-Gil, A, Ezcura-Díaz, G, Arzamendi-Aizpurua, D, Martí-Fàbregas, J. Left atrial appendage occlusion in patients with spontaneous intracerebral hemorrhage: An observational study. Journal of Stroke & Cerebrovascular Diseases. 2024; 33(2)DOI:10.1016/j.jstrokecerebrovasdis.2023.107481. PMID:38064973. IF:1.800(Q3/7D).
01/07/2023
Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation
Soo, Y, Zietz, A, Yiu, B, Mok, VCT, Polymeris, AA, Seiffge, D, Ambler, G, Wilson, D, Leung, TWH, Tsang, SF, Chu, W, Abrigo, J, Cheng, C, Lee, KJ, Lim, JS, Shiozawa, M, Koga, M, Chabriat, H, Hennerici, M, Wong, YK, Mak, H, Collet, R, Inamura, S, Yoshifuji, K, Arsava, EM, Horstmann, S, Purrucker, J, Lam, BYK, Wong, A, Kim, YD, Song, TJ, Lemmens, R, Eppinger, S, Gattringer, T, Uysal, E, Demirelli, DS, Bornstein, NM, Ben Assayag, E, Hallevi, H, Molad, J, Nishihara, M, Tanaka, J, Coutts, SB, Kappelle, LJ, Salman, RA, Jager, R, Lip, GYH, Goeldlin, MB, Panos, LD, Mas, JL, Legrand, L, Karayiannis, C, Phan, T, Bellut, M, Chappell, F, Makin, S, Hayden, D, Williams, D, van Dam-Nolen, DHK, Nederkoorn, PJ, Barbato, C, Browning, S, Wiegertjes, K, Tuladhar, AM, Mendyk, AM, Kohler, S, van Oostenburgge, R, Zhou, Y, Xu, C, Hilal, S, Gyanwali, B, Chen, C, Lou, M, Staals, J, Bordet, R, Kandiah, N, de Leeuw, FE, Simister, R, Hendrikse, J, Wardlaw, J, Kelly, P, Fluri, F, Srikanth, V, Calvet, D, Jung, S, Kwa, VIH, Smith, EE, Hara, H, Yakushiji, Y, Orken, DN, Fazekas, F, Thijs, V, Heo, JH, Veltkamp, R, Ay, H, Imaizumi, T, Lau, KK, Jouvent, E, Toyoda, K, Yoshimura, S, Bae, HJ, Marti-Fabregas, J, Prats-Sanchez, L, Lyrer, P, Best, J, Werring, D, Engelter, ST, Peters, N. Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation. ANNALS OF NEUROLOGY. 2023; 94(1)DOI:10.1002/ana.26642. PMID:36928609. IF:8.100(Q1/1D).
01/01/2023
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants
Meinel T.R., Wilson D., Gensicke H., Scheitz J.F., Ringleb P., Goganau I., Kaesmacher J., Bae H.-J., Kim D.Y., Kermer P., Suzuki K., Kimura K., Macha K., Koga M., Wada S., Altersberger V., Salerno A., Palanikumar L., Zini A., Forlivesi S., Kellert L., Wischmann J., Kristoffersen E.S., Beharry J., Barber P.A., Hong J.B., Cereda C., Schlemm E., Yakushiji Y., Poli S., Leker R., Romoli M., Zedde M., Curtze S., Ikenberg B., Uphaus T., Giannandrea D., Portela P.C., Veltkamp R., Ranta A., Arnold M., Fischer U., Cha J.-K., Wu T.Y., Purrucker J.C., Seiffge D.J., Kägi G., Engelter S., Nolte C.H., Kallmünzer B., Michel P., Kleinig T.J., Fink J., Rønning O.M., Campbell B., Nederkoorn P.J., Thomalla G., Kunieda T., Poli K., Béjot Y., Soo Y., Garcia-Esperon C., Ntaios G., Cordonnier C., Marto J.P., Bigliardi G., Lun F., Choi P.M.C., Steiner T., Ustrell X., Werring D., Wegener S., Pezzini A., Du H., Martí-Fàbregas J., Cánovas-Vergé D., Strbian D., Padjen V., Yaghi S., Stretz C., Kim J.-T.. Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants. JAMA Neurology. 2023; 80(3)DOI:10.1001/jamaneurol.2022.4782. PMID:36807495. IF:20.900(Q1/1D).
01/06/2022
Identification of serum microRNAs as potential biomarkers in Pompe disease (vol 6, pg 1214, 2019)
Carrasco-Rozas, A, Fernandez-Simon, E, Lleixa, MC, Belmonte, I, Pedrosa-Hernandez, I, Montiel-Morillo, E, Nunez-Peralta, C, Rossello, JL, Segovia, S, De Luna, N, Suarez-Calvet, X, Illa, I, Diaz-Manera, J, Gallardo, E, Barba-Romero, MA, Barcena, J, Carzorla, MR, Creus, C, Coll-Canti, J, Diaz, M, Dominguez, C, Torron, RF, Antelo, MJG, Grau, JM, Caravaca, MTG, Hernandez, JCL, de Munain, AL, Martinez-Garcia, FA, Morgado, Y, Moreno, A, Moris, G, Munoz-Blanco, MA, Nascimento, A, Paradas, C, Pozo, JLP, Querol, L, Robledo-Strauss, A, Garcia, RR, Rojas-Marcos, I, Salazar, JA, Uson, M. Identification of serum microRNAs as potential biomarkers in Pompe disease (vol 6, pg 1214, 2019). Annals of Clinical and Translational Neurology. 2022; 9(6)DOI:10.1002/acn3.51600. PMID:31353854. IF:5.300(Q1/2D).
01/10/2021
Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP)
Querol, L, Crabtree, M, Herepath, M, Priedane, E, Viejo, IV, Agush, S, Sommerer, P. Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP). JOURNAL OF NEUROLOGY. 2021; 268(10)DOI:10.1007/s00415-020-09998-8. PMID:32583051. IF:6.682(Q1/2D).
01/07/2022
Motor neuron involvement expands the neuropathological phenotype of late-onset ataxia in RFC1 mutation (CANVAS)
Reyes-Leiva, D, Aldecoa, I, Gelpi, E, Rojas-Garcia, R. Motor neuron involvement expands the neuropathological phenotype of late-onset ataxia in RFC1 mutation (CANVAS). BRAIN PATHOLOGY. 2022; 32(4)DOI:10.1111/bpa.13051. PMID:35001451. IF:6.400(Q1/2D).
01/07/2022
Muscle MRI characteristic pattern for late-onset TK2 deficiency diagnosis
Dominguez-Gonzalez, C, Fernandez-Torron, R, Moore, U, de la Hoz, CPDF, Velez-Gomez, B, Cabezas, JA, Alonso-Perez, J, Gonzalez-Mera, L, Olive, M, Garcia-Garcia, J, Moris, G, Hernandez, JCL, Muelas, N, Servian-Morilla, E, Martin, MA, Diaz-Manera, J, Paradas, C. Muscle MRI characteristic pattern for late-onset TK2 deficiency diagnosis. JOURNAL OF NEUROLOGY. 2022; 269(7)DOI:10.1007/s00415-021-10957-0. PMID:35286480. IF:6.000(Q1/2D).
01/06/2022
Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database
Liberatore, G, De Lorenzo, A, Giannotta, C, Manganelli, F, Filosto, M, Cosentino, G, Cocito, D, Briani, C, Cortese, A, Fazio, R, Lauria, G, Clerici, AM, Rosso, T, Marfia, GA, Antonini, G, Cavaletti, G, Carpo, M, Doneddu, PE, Spina, E, Piccinelli, SC, Peci, E, Querol, L, Nobile-Orazio, E. Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database. NEUROLOGICAL SCIENCES. 2022; 43(6)DOI:10.1007/s10072-021-05811-0. PMID:35048233. IF:3.300(Q2/5D).
01/05/2022
Clinical and genetic features of a large homogeneous cohort of oculopharyngeal muscular dystrophy patients from the Canary Islands
Alonso-Perez, J, Hernandez, JCD, Perez-Perez, H, Mendoza-Grimon, MD, Gutierrez-Martinez, AJ, Hadjigeorgiou, I, Monton-Alvarez, F, Gonzalez-Quereda, L, Alonso-Jimenez, A, Suarez-Calvet, X, Diaz-Manera, J. Clinical and genetic features of a large homogeneous cohort of oculopharyngeal muscular dystrophy patients from the Canary Islands. EUROPEAN JOURNAL OF NEUROLOGY. 2022; 29(5)DOI:10.1111/ene.15252. PMID:35112761. IF:5.100(Q1/3D).
01/05/2022
Cardiac and pulmonary findings in dysferlinopathy: A 3-year, longitudinal study
Moore, U, Fernandez-Torron, R, Jacobs, M, Gordish-Dressman, H, Diaz-Manera, J, James, MK, Mayhew, AG, Harris, E, Guglieri, M, Rufibach, LE, Feng, J, Blamire, AM, Carlier, PG, Spuler, S, Day, JW, Jones, KJ, Bharucha-Goebel, DX, Salort-Campana, E, Pestronk, A, Walter, MC, Paradas, C, Stojkovic, T, Mori-Yoshimura, M, Bravver, E, Pegoraro, E, Lowes, LP, Mendell, JR, Bushby, K, Bourke, J, Straub, V, Jain COS Consortium. Cardiac and pulmonary findings in dysferlinopathy: A 3-year, longitudinal study. MUSCLE & NERVE. 2022; 65(5)DOI:10.1002/mus.27524. PMID:35179231. IF:3.400(Q2/5D).
01/05/2022
High prevalence of paraspinal muscle involvement in adults with McArdle disease
Alvarez-Velasco, R, Nunez-Peralta, CA, Alonso-Perez, J, Gallardo, E, Collet-Vidiella, R, Reyes-Leiva, D, Pascual-Goni, E, Martin-Aguilar, L, Caballero-Avila, M, Carbayo-Viejo, A, Llauger-Rosello, J, Diaz-Manera, J, Olive, M. High prevalence of paraspinal muscle involvement in adults with McArdle disease. MUSCLE & NERVE. 2022; 65(5)DOI:10.1002/mus.27523. PMID:35174518. IF:3.400(Q2/5D).
18/04/2022
Clinical and genetic spectrum of a large cohort of patients with delta-sarcoglycan muscular dystrophy
Alonso-Perez, J, Gonzalez-Quereda, L, Bruno, C, Panicucci, C, Alavi, A, Nafissi, S, Nilipour, Y, Zanoteli, E, Isihi, LMD, Melegh, B, Hadzsiev, K, Muelas, N, Vilchez, JJ, Dourado, ME, Kadem, N, Kutluk, G, Umair, M, Younus, M, Pegorano, E, Bello, L, Crawford, TO, Suarez-Calvet, X, Topf, A, Guglieri, M, Marini-Bettolo, C, Gallano, P, Straub, V, Diaz-Manera, J. Clinical and genetic spectrum of a large cohort of patients with delta-sarcoglycan muscular dystrophy. BRAIN. 2022; 145(2)DOI:10.1093/brain/awab301. PMID:34515763. IF:14.500(Q1/1D).
01/03/2022
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials
Garibaldi, M, Nicoletti, T, Bucci, E, Fionda, L, Leonardi, L, Morino, S, Tufano, L, Alfieri, G, Lauletta, A, Merlonghi, G, Perna, A, Rossi, S, Ricci, E, Perez, JA, Tartaglione, T, Petrucci, A, Pennisi, EM, Salvetti, M, Cutter, G, Diaz-Manera, J, Silvestri, G, Antonini, G. Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials. EUROPEAN JOURNAL OF NEUROLOGY. 2022; 29(3)DOI:10.1111/ene.15174. PMID:34753219. IF:5.100(Q1/3D).
01/03/2022
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision (vol 1, pg 3556, 2021)
van den Bergh, PYK, van Doorn, PA, Hadden, RDM, Avau, B, Vankrunkelsven, P, Allen, JA, Attarian, S, Blomkwist-Markens, PH, Cornblath, DR, Eftimov, F, Goedee, HS, Harbo, T, Kuwabara, S, Lewis, RA, Lunn, MP, Nobile-Orazio, E, Querol, L, Rajabally, YA, Sommer, C, Topaloglu, HA. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision (vol 1, pg 3556, 2021). JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2022; 27(1)DOI:10.1111/jns.12479. PMID:. IF:3.800(Q2/4D).
01/03/2022
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (vol 53, pg 1636, 2021)
van Rheenen, W, van der Spek, RAA, Bakker, MK, van Vugt, JJFA, Hop, PJ, Zwamborn, RAJ, de Klein, N, Westra, HJ, Bakker, OB, Deelen, P, Shireby, G, Hannon, E, Moisse, M, Baird, D, Restuadi, R, Dolzhenko, E, Dekker, AM, Gawor, K, Westeneng, HJ, Tazelaar, GHP, van Eijk, KR, Kooyman, M, Byrne, RP, Doherty, M, Heverin, M, Al Khleifat, A, Iacoangeli, A, Shatunov, A, Ticozzi, N, Cooper-Knock, J, Smith, BN, Gromicho, M, Chandran, S, Pal, S, Morrison, KE, Shaw, PJ, Hardy, J, Orrell, RW, Sendtner, M, Meyer, T, Basak, N, van der Kooi, AJ, Ratti, A, Fogh, I, Gellera, C, Lauria, G, Corti, S, Cereda, C, Sproviero, D, Soraru, G, Siciliano, G, Filosto, M, Padovani, A, Chio, A, Calvo, A, Moglia, C, Brunetti, M, Canosa, A, Grassano, M, Beghi, E, Pupillo, E, Logroscino, G, Nefussy, B, Osmanovic, A, Nordin, A, Lerner, Y, Zabari, M, Gotkine, M, Baloh, RH, Bell, S, Vourc'h, P, Corcia, P, Couratier, P, Millecamps, S, Meininger, V, Salachas, F, Pardina, JMS, Assialioui, A, Rojas-Garcia, R, Dion, PA, Ross, JP, Ludolph, AC, Weishaupt, JH, Brenner, D, Freischmidt, A, Bensimon, G, Brice, A, Durr, A, Payan, CAM, Saker-Delye, S, Wood, NW, Topp, S, Rademakers, R, Tittmann, L, Lieb, W, Franke, A, Ripke, S, Braun, A, Kraft, J, Whiteman, DC, Olsen, CM, Uitterlinden, AG, Hofman, A, Rietschel, M, Cichon, S, Nothen, MM, Amouyel, P, Comi, G, Riva, N, Lunetta, C, Gerardi, F, Cotelli, MS, Rinaldi, F, Chiveri, L, Guaita, MC, Perrone, P, Diamanti, L, Ferrarese, C, Tremolizzo, L, Delodovici, ML, Bono, G, Manera, U, Vasta, R, Bombaci, A, Casale, F, Fuda, G, Salamone, P, Iazzolino, B, Peotta, L, Cugnasco, P, De Marco, G, Torrieri, MC, Palumbo, F, Gallone, S, Barberis, M, Sbaiz, L, Gentile, S, Mauro, A, De Marchi, F, D'Alfonso, S, Bertolotto, A, Gionco, M, Leotta, D, Odddenino, E, Imperiale, D, Cavallo, R, Pignatta, P, De Mattei, M, Geda, C, Papurello, DM, Gusmaroli, G, Comi, C, Labate, C, Ruiz, L, Ferrandi, D, Rota, E, Aguggia, M, Di Vito, N, Meineri, P, Ghiglione, P, Launaro, N, Dotta, M, Di Sapio, A, Giardini, G, Tiloca, C, Peverelli, S, Taroni, F, Pensato, V, Castellotti, B, Comi, GP, Del Bo, R, Ceroni, M, Gagliardi, S, Corrado, L, Mazzini, L, Raggi, F, Simoncini, C, Lo Gerfo, A, Inghilleri, M, Ferlini, A, Simone, IL, Passarella, B, Guerra, V, Zoccolella, S, Nozzoli, C, Mundi, C, Leone, M, Zarrelli, M, Tamma, F, Valluzzi, F, Calabrese, G, Boero, G, Rini, A, Traynor, BJ, Singleton, AB, Neto, MM, Cauchi, RJ, Ophoff, RA, Wiedau-Pazos, M, Lomen-Hoerth, C, van Deerlin, VM, Grosskreutz, J, Roediger, A, Gaur, N, Jork, A, Barthel, T, Theele, E, Ilse, B, Stubendorff, B, Witte, OW, Steinbach, R, Hubner, CA, Graff, C, Brylev, L, Fominykh, V, Demeshonok, V, Ataulina, A, Rogelj, B, Koritnik, B, Zidar, J, Ravnik-Glavac, M, Glavac, D, Stevic, Z, Drory, V, Povedano, M, Blair, IP, Kiernan, MC, Benyamin, B, Henderson, RD, Furlong, S, Mathers, S, McCombe, PA, Needham, M, Ngo, ST, Nicholson, GA, Pamphlett, R, Rowe, DB, Steyn, FJ, Williams, KL, Mather, KA, Sachdev, PS, Henders, AK, Wallace, L, de Carvalho, M, Pinto, S, Petri, S, Weber, M, Rouleau, GA, Silani, V, Curtis, CJ, Breen, G, Glass, JD, Brown, RH, Landers, JE, Shaw, CE, Andersen, PM, Groen, EJN, van Es, MA, Pasterkamp, RJ, Fan, DS, Garton, FC, McRae, AF, Smith, GD, Gaunt, TR, Eberle, MA, Mill, J, McLaughlin, RL, Hardiman, O, Kenna, KP, Wray, NR, Tsai, EL, Runz, H, Franke, L, Al-Chalabi, A, Van Damme, P, van den Berg, LH, Veldink, JH, SLALOM Consortium, PARALS Consortium, SLAGEN Consortium, SLAP Consortium. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (vol 53, pg 1636, 2021). NATURE GENETICS. 2022; 54(3)DOI:10.1038/s41588-022-01020-3. PMID:35102318. IF:30.800(Q1/1D).
01/02/2022
Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome
Cortes-Vicente, E, Alvarez-Velasco, R, Pla-Junca, F, Rojas-Garcia, R, Paradas, C, Sevilla, T, Casasnovas, C, Gomez-Caravaca, MT, Pardo, J, Ramos-Fransi, A, Pelayo-Negro, AL, Gutierrez-Gutierrez, G, Turon-Sans, J, de Munain, AL, Guerrero-Sola, A, Jerico, I, Martin, MA, Mendoza, MD, Moris, G, Velez-Gomez, B, Garcia-Sobrino, T, Pascual-Goni, E, Reyes-Leiva, D, Illa, I, Gallardo, E. Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome. Annals of Clinical and Translational Neurology. 2022; 9(2)DOI:10.1002/acn3.51492. PMID:35080153. IF:5.300(Q1/2D).
01/01/2022
Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy
Martín-Aguilar L, Lleixà C, Pascual-Goñi E, Caballero-Ávila M, Martínez-Martínez L, Díaz-Manera J, Rojas-García R, Cortés-Vicente E, Turon-Sans J, de Luna N, Suárez-Calvet X, Gallardo E, Rajabally Y, Scotton S, Jacobs BC, Baars A, Cortese A, Vegezzi E, Höftberger R, Zimprich F, Roesler C, Nobile-Orazio E, Liberatore G, Hiew FL, Martínez-Piñeiro A, Carvajal A, Piñar-Morales R, Usón-Martín M, Albertí O, López-Pérez MÁ, Márquez F, Pardo-Fernández J, Muñoz-Delgado L, Cabrera-Serrano M, Ortiz N, Bartolomé M, Duman Ö, Bril V, Segura-Chávez D, Pitarokoili K, Steen C, Illa I, Querol L. Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy. Neurology-Neuroimmunology & Neuroinflammation. 2022; 9(1)DOI:10.1212/NXI.0000000000001098. PMID:34728497. IF:8.800(Q1/1D).
01/12/2021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
van Rheenen, W, van der Spek, RAA, Bakker, MK, van Vugt, JJFA, Hop, PJ, Zwamborn, RAJ, de Klein, N, Westra, HJ, Bakker, OB, Deelen, P, Shireby, G, Hannon, E, Moisse, M, Baird, D, Restuadi, R, Dolzhenko, E, Dekker, AM, Gawor, K, Westeneng, HJ, Tazelaar, GHP, van Eijk, KR, Kooyman, M, Byrne, RP, Doherty, M, Heverin, M, Al Khleifat, A, Iacoangeli, A, Shatunov, A, Ticozzi, N, Cooper-Knock, J, Smith, BN, Gromicho, M, Chandran, S, Pal, S, Morrison, KE, Shaw, PJ, Hardy, J, Orrell, RW, Sendtner, M, Meyer, T, Basak, N, van der Kooi, AJ, Ratti, A, Fogh, I, Gellera, C, Lauria, G, Corti, S, Cereda, C, Sproviero, D, Soraru, G, Siciliano, G, Filosto, M, Padovani, A, Chio, A, Calvo, A, Moglia, C, Brunetti, M, Canosa, A, Grassano, M, Beghi, E, Pupillo, E, Logroscino, G, Nefussy, B, Osmanovic, A, Nordin, A, Lerner, Y, Zabari, M, Gotkine, M, Baloh, RH, Bell, S, Vourc'h, P, Corcia, P, Couratier, P, Millecamps, S, Meininger, V, Salachas, F, Pardina, JMS, Assialioui, A, Rojas-Garcia, R, Dion, PA, Ross, JP, Ludolph, AC, Weishaupt, JH, Brenner, D, Freischmidt, A, Bensimon, G, Brice, A, Durr, A, Payan, CAM, Saker-Delye, S, Wood, NW, Topp, S, Rademakers, R, Tittmann, L, Lieb, W, Franke, A, Ripke, S, Braun, A, Kraft, J, Whiteman, DC, Olsen, CM, Uitterlinden, AG, Hofman, A, Rietschel, M, Cichon, S, Nothen, MM, Amouyel, P, Comi, G, Riva, N, Lunetta, C, Gerardi, F, Cotelli, MS, Rinaldi, F, Chiveri, L, Guaita, MC, Perrone, P, Diamanti, L, Ferrarese, C, Tremolizzo, L, Delodovici, ML, Bono, G, Manera, U, Vasta, R, Bombaci, A, Casale, F, Fuda, G, Salamone, P, Iazzolino, B, Peotta, L, Cugnasco, P, De Marco, G, Torrieri, MC, Palumbo, F, Gallone, S, Barberis, M, Sbaiz, L, Gentile, S, Mauro, A, De Marchi, F, D'Alfonso, S, Bertolotto, A, Gionco, M, Leotta, D, Odddenino, E, Imperiale, D, Cavallo, R, Pignatta, P, De Mattei, M, Geda, C, Papurello, DM, Gusmaroli, G, Comi, C, Labate, C, Ruiz, L, Ferrandi, D, Rota, E, Aguggia, M, Di Vito, N, Meineri, P, Ghiglione, P, Launaro, N, Dotta, M, Di Sapio, A, Giardini, G, Tiloca, C, Peverelli, S, Taroni, F, Pensato, V, Castellotti, B, Comi, GP, Del Bo, R, Ceroni, M, Gagliardi, S, Corrado, L, Mazzini, L, Raggi, F, Simoncini, C, Lo Gerfo, A, Inghilleri, M, Ferlini, A, Simone, IL, Passarella, B, Guerra, V, Zoccolella, S, Nozzoli, C, Mundi, C, Leone, M, Zarrelli, M, Tamma, F, Valluzzi, F, Calabrese, G, Boero, G, Rini, A, Traynor, BJ, Singleton, AB, Neto, MM, Cauchi, RJ, Ophoff, RA, Wiedau-Pazos, M, Lomen-Hoerth, C, van Deerlin, VM, Grosskreutz, J, Roediger, A, Gaur, N, Jork, A, Barthel, T, Theele, E, Ilse, B, Stubendorff, B, Witte, OW, Steinbach, R, Hubner, CA, Graff, C, Brylev, L, Fominykh, V, Demeshonok, V, Ataulina, A, Rogelj, B, Koritnik, B, Zidar, J, Ravnik-Glavac, M, Glavac, D, Stevic, Z, Drory, V, Povedano, M, Blair, IP, Kiernan, MC, Benyamin, B, Henderson, RD, Furlong, S, Mathers, S, McCombe, PA, Needham, M, Ngo, ST, Nicholson, GA, Pamphlett, R, Rowe, DB, Steyn, FJ, Williams, KL, Mather, KA, Sachdev, PS, Henders, AK, Wallace, L, de Carvalho, M, Pinto, S, Petri, S, Weber, M, Rouleau, GA, Silani, V, Curtis, CJ, Breen, G, Glass, JD, Brown, RH, Landers, JE, Shaw, CE, Andersen, PM, Groen, EJN, van Es, MA, Pasterkamp, RJ, Fan, DS, Garton, FC, McRae, AF, Smith, GD, Gaunt, TR, Eberle, MA, Mill, J, McLaughlin, RL, Hardiman, O, Kenna, KP, Wray, NR, Tsai, EL, Runz, H, Franke, L, Al-Chalabi, A, Van Damme, P, van den Berg, LH, Veldink, JH. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. NATURE GENETICS. 2021; 53(12)DOI:10.1038/s41588-021-00973-1. PMID:34873335. IF:41.376(Q1/1D).
01/12/2021
Optic Nerve Demyelination in IgG4 Anti-Neurofascin 155 Antibody-Positive Combined Central and Peripheral Demyelination Syndrome
Verghese, A, Krishnan, D, Chia, YK, Querol, L, Hiew, FL. Optic Nerve Demyelination in IgG4 Anti-Neurofascin 155 Antibody-Positive Combined Central and Peripheral Demyelination Syndrome. Journal Of Central Nervous System Disease. 2021; 13DOI:10.1177/11795735211039913. PMID:34899003. IF:(Q/D).
01/12/2021
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
Diaz-Manera, J, Kishnani, PS, Kushlaf, H, Ladha, S, Mozaffar, T, Straub, V, Toscano, A, Van der Ploeg, AT, Berger, KI, Clemens, PR, Chien, YH, Day, JW, Illarioshkin, S, Roberts, M, Attarian, S, Borges, JL, Bouhour, F, Choi, YC, Erdem-Ozdamar, S, Goker-Alpan, O, Kostera-Pruszczyk, A, Haack, KA, Hug, C, Huynh-Ba, O, Johnson, J, Thibault, N, Zhou, TY, Dimachkie, MM, Schoser, B. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial. LANCET NEUROLOGY. 2021; 20(12)DOI:10.1016/S1474-4422(21)00241-6. PMID:34800399. IF:59.935(Q1/1D).
01/11/2021
Autoantibody screening in Guillain-Barre syndrome
Lleixa, C, Martin-Aguilar, L, Pascual-Goni, E, Franco, T, Caballero, M, De Luna, N, Gallardo, E, Suarez-Calvet, X, Martinez-Martinez, L, Diaz-Manera, J, Rojas-Garcia, R, Cortes-Vicente, E, Turon, J, Casasnovas, C, Homedes, C, Gutierrez-Gutierrez, G, Jimeno-Montero, MC, Berciano, J, Sedano-Tous, MJ, Garcia-Sobrino, T, Pardo-Fernandez, J, Marquez-Infante, C, Rojas-Marcos, I, Jerico-Pascual, I, Martinez-Hernandez, E, de la Tassa, GM, Dominguez-Gonzalez, C, Juarez, C, Illa, I, Querol, L. Autoantibody screening in Guillain-Barre syndrome. Journal of Neuroinflammation. 2021; 18(1)DOI:10.1186/s12974-021-02301-0. PMID:34719386. IF:9.589(Q1/1D).
01/11/2021
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision
Van den Bergh, PYK, van Doorn, PA, Hadden, RDM, Avau, B, Vankrunkelsven, P, Allen, JA, Attarian, S, Blomkwist-Markens, PH, Cornblath, DR, Eftimov, F, Goedee, HS, Harbo, T, Kuwabara, S, Lewis, RA, Lunn, MP, Nobile-Orazio, E, Querol, L, Rajabally, YA, Sommer, C, Topaloglu, HA. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. EUROPEAN JOURNAL OF NEUROLOGY. 2021; 28(11)DOI:10.1111/ene.14959. PMID:. IF:6.288(Q1/2D).
01/11/2021
Fifteen years of enzyme therapy in Pompe disease
Diaz-Manera, J. Fifteen years of enzyme therapy in Pompe disease. REVISTA DE NEUROLOGIA. 2021; 73(9)DOI:10.33588/rn.7309.2021382. PMID:34676531. IF:1.235(Q4/10D).
01/11/2021
Guillain-Barre syndrome after SARS-CoV-2 infection in an international prospective cohort study
Luijten, LWG, Leonhard, SE, van der Eijk, AA, Doets, AY, Appeltshauser, L, Arends, S, Attarian, S, Benedetti, L, Briani, C, Casasnovas, C, Castellani, F, Dardiotis, E, Echaniz-Laguna, A, Garssen, MPJ, Harbo, T, Huizinga, R, Humm, AM, Jellema, K, van der Kooi, AJ, Kuitwaard, K, Kuntzer, T, Kusunoki, S, Lascano, AM, Martinez-Hernandez, E, Rinaldi, S, Samijn, JPA, Scheidegger, O, Tsouni, P, Vicino, A, Visser, LH, Walgaard, C, Wang, YZ, Wirtz, PW, Ripellino, P, Jacobs, BC, Martín-Aguilar L, Zivkovic, Sasa A.. Guillain-Barre syndrome after SARS-CoV-2 infection in an international prospective cohort study. BRAIN. 2021; 144(11)DOI:10.1093/brain/awab279. PMID:34553216. IF:15.255(Q1/1D).
02/10/2021
Collaborative model for diagnosis and treatment of very rare diseases: experience in Spain with thymidine kinase 2 deficiency
Dominguez-Gonzalez, C, Madruga-Garrido, M, Hirano, M, Marti, I, Martin, MA, Munell, F, Nascimento, A, Olive, M, Quan, J, Sardina, MD, Marti, R, Paradas, C. Collaborative model for diagnosis and treatment of very rare diseases: experience in Spain with thymidine kinase 2 deficiency. Orphanet Journal of Rare Diseases. 2021; 16(1)DOI:10.1186/s13023-021-02030-w. PMID:34600563. IF:4.302(Q2/4D).
01/10/2021
Autoimmune nodopathies: treatable neuropathies beyond traditional classifications comment
Querol, L. Autoimmune nodopathies: treatable neuropathies beyond traditional classifications comment. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2021; 92(10)DOI:10.1136/jnnp-2021-326676. PMID:34400541. IF:13.654(Q1/1D).
01/10/2021
Novel Immunological and Therapeutic Insights in Guillain-Barre Syndrome and CIDP
Querol, L, Lleixa, C. Novel Immunological and Therapeutic Insights in Guillain-Barre Syndrome and CIDP. Neurotherapeutics. 2021; 18(4)DOI:10.1007/s13311-021-01117-3. PMID:34549385. IF:6.088(Q1/2D).
01/10/2021
The Genetic Landscape of Mitochondrial Diseases in Spain: A Nationwide Call
Bellusci, M, Paredes-Fuentes, AJ, Ruiz-Pesini, E, Gomez, B, Martin, MA, Montoya, J, Artuch, R, Grp, Díaz-Manera J., Gallardo, E. The Genetic Landscape of Mitochondrial Diseases in Spain: A Nationwide Call. Genes. 2021; 12(10)DOI:10.3390/genes12101590. PMID:34680984. IF:4.141(Q2/5D).
15/09/2021
Comment to "Autoantibodies to cortactin and agrin in sera of patients with myasthenia gravis"
Cortes-Vicente, E, Alvarez-Velasco, R, Illa, I, Gallardo, E. Comment to "Autoantibodies to cortactin and agrin in sera of patients with myasthenia gravis". JOURNAL OF NEUROIMMUNOLOGY. 2021; 358DOI:10.1016/j.jneuroim.2021.577659. PMID:34273889. IF:3.221(Q3/7D).
01/09/2021
TREAT-NMD stakeholder meeting for natural history studies in limb girdle muscular dystrophy 18th June 2019, Amsterdam, The Netherlands
Guglieri, M, Diaz-Manera, J, Straub, V. TREAT-NMD stakeholder meeting for natural history studies in limb girdle muscular dystrophy 18th June 2019, Amsterdam, The Netherlands. NEUROMUSCULAR DISORDERS. 2021; 31(9)DOI:10.1016/j.nmd.2021.06.011. PMID:34426054. IF:3.538(Q2/5D).
01/09/2021
Serum Contactin-1 in CIDP A Cross-Sectional Study
Wieske, L, Martin-Aguilar, L, Fehmi, J, Lleixa, C, Koel-Simmelink, MJA, Chatterjee, M, van Lierop, Z, Killestein, J, Verhamme, C, Querol, L, Rinaldi, S, Teunissen, CE, Eftimov, F. Serum Contactin-1 in CIDP A Cross-Sectional Study. Neurology-Neuroimmunology & Neuroinflammation. 2021; 8(5)DOI:10.1212/NXI.0000000000001040. PMID:34285092. IF:11.360(Q1/1D).
01/09/2021
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision
Van den Bergh, PYK, van Doorn, PA, Hadden, RDM, Avau, B, Vankrunkelsven, P, Allen, JA, Attarian, S, Blomkwist-Markens, PH, Cornblath, DR, Eftimov, F, Goedee, HS, Harbo, T, Kuwabara, S, Lewis, RA, Lunn, MP, Nobile-Orazio, E, Querol, L, Rajabally, YA, Sommer, C, Topaloglu, HA. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2021; 26(3)DOI:10.1111/jns.12455. PMID:34085743. IF:5.188(Q2/3D).
01/09/2021
Charcot-Marie-Tooth disease due to MORC2 mutations in Spain
Sivera, R, Lupo, V, Frasquet, M, Argente-Escrig, H, Alonso-Perez, J, Diaz-Manera, J, Querol, L, Garcia-Romero, MD, Pascual, SI, Garcia-Sobrino, T, Paradas, C, Vazquez-Costa, JF, Muelas, N, Millet, E, Vilchez, JJ, Espinos, C, Sevilla, T. Charcot-Marie-Tooth disease due to MORC2 mutations in Spain. EUROPEAN JOURNAL OF NEUROLOGY. 2021; 28(9)DOI:10.1111/ene.15001. PMID:34189813. IF:6.288(Q1/2D).
01/08/2021
Late onset Sandhoff disease presenting with lower motor neuron disease and stuttering
Alonso-Perez, J, Casasus, A, Gimenez-Munoz, A, Duff, J, Rojas-Garcia, R, Illa, I, Straub, V, Topf, A, Diaz-Manera, J. Late onset Sandhoff disease presenting with lower motor neuron disease and stuttering. NEUROMUSCULAR DISORDERS. 2021; 31(8)DOI:10.1016/j.nmd.2021.04.011. PMID:34210542. IF:3.538(Q2/5D).
29/07/2021
Quantifying the patient ' s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire
Meca-Lallana, JE, Maurino, J, Perez-Miralles, F, Forero, L, Sepulveda, M, Calles, C, Martinez-Gines, ML, Gonzalez-Suarez, I, Boyero, S, Romero-Pinel, L, Sempere, AP, Meca-Lallana, V, Querol, L, Costa-Frossard, L, Prefasi, D, Gomez-Ballesteros, R, Ballesteros, J. Quantifying the patient ' s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire. PLoS One. 2021; 16(7)DOI:10.1371/journal.pone.0255317. PMID:34324586. IF:3.752(Q2/4D).
13/07/2021
Magnetization Transfer Ratio in Lower Limbs of Late Onset Pompe Patients Correlates With Intramuscular Fat Fraction and Muscle Function Tests (vol 12, 634766, 2021)
Nunez-Peralta, C, Montesinos, P, Alonso-Jimenez, A, Alonso-Perez, J, Reyes-Leiva, D, Sanchez-Gonzalez, J, Llauger-Rosello, J, Segovia, S, Belmonte, I, Pedrosa, I, Martinez-Noguera, A, Matellini-Mosca, B, Walter, G, Diaz-Manera, J. Magnetization Transfer Ratio in Lower Limbs of Late Onset Pompe Patients Correlates With Intramuscular Fat Fraction and Muscle Function Tests (vol 12, 634766, 2021). Frontiers in Neurology. 2021; 12DOI:10.3389/fneur.2021.727020. PMID:34326809. IF:4.086(Q2/5D).
03/07/2021
Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practice
Allen, JA, Eftimov, F, Querol, L. Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practice. Expert Review of Neurotherapeutics. 2021; 21(7)DOI:10.1080/14737175.2021.1944104. PMID:34130574. IF:4.287(Q2/4D).
01/07/2021
STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa
Gutschmidt, K, Musumeci, O, Diaz-Manera, J, Chien, YH, Knop, KC, Wenninger, S, Montagnese, F, Pugliese, A, Tavilla, G, Alonso-Perez, J, Hwu, PWL, Toscano, A, Schoser, B. STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa. JOURNAL OF NEUROLOGY. 2021; 268(7)DOI:10.1007/s00415-021-10409-9. PMID:33543425. IF:6.682(Q1/2D).
01/07/2021
Psychotic symptoms in drug resistant epilepsy patients after cortical stimulation
Conde-Blanco, E, Reyes-Leiva, D, Pintor, L, Donaire, A, Manzanares, I, Rumia, J, Roldan, P, Boget, T, Bargallo, N, Gil-Lopez, FJ, Khawaja, M, Setoain, X, Centeno, M, Carreno, M. Psychotic symptoms in drug resistant epilepsy patients after cortical stimulation. EPILEPSY RESEARCH. 2021; 173DOI:10.1016/j.eplepsyres.2021.106630. PMID:33865048. IF:2.991(Q3/7D).
01/07/2023
The role of specialist nurses in detecting spasticity and related symptoms in multiple sclerosis
Artola, M, Hernando, A, Vidal, O, Vidal, N, Cuenca, E, Horno, R, Robles, MA, Oriol, C, Peralta, S, Solana, MAJ, Rubio, M, Montero, C, Lleixa, M, Zabay, C, Martin, M, Leon, I, Molinos, C, Matamoros, M, Mercade, L, Fornali, O, Montero, L, Saiz, A, Sola-Valls, N. The role of specialist nurses in detecting spasticity and related symptoms in multiple sclerosis. JOURNAL OF CLINICAL NURSING. 2023; 32(13-14)DOI:10.1111/jocn.16421. PMID:35799407. IF:3.200(Q1/1D).
01/01/2023
Loss of function variants in DNAJB4 cause a myopathy with early respiratory failure
Weihl C.C., Topf, A, Bengoechea R., Duff J., Charlton R., Garcia S.K., Domínguez-González C., Alsaman A., Hernández-Laín A., Franco L.V., Sanchez, MEP, Beecroft S.J., Goullee H., Daw J., Bhadra A., True H., Inoue M., Findlay A.R., Laing N., Olivé M., Ravenscroft G., Straub V.. Loss of function variants in DNAJB4 cause a myopathy with early respiratory failure. ACTA NEUROPATHOLOGICA. 2023; 145(1)DOI:10.1007/s00401-022-02510-8. PMID:36264506. IF:9.300(Q1/1D).